0001734920-18-000001.txt : 20180417 0001734920-18-000001.hdr.sgml : 20180417 20180417110157 ACCESSION NUMBER: 0001734920-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20180417 DATE AS OF CHANGE: 20180417 EFFECTIVENESS DATE: 20180417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NGN Optiscan Fund I, L.P. CENTRAL INDEX KEY: 0001734920 IRS NUMBER: 824393034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310325 FILM NUMBER: 18758205 BUSINESS ADDRESS: STREET 1: 369 LEXINGTON AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 972-0077 MAIL ADDRESS: STREET 1: 369 LEXINGTON AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001734920 NGN Optiscan Fund I, L.P. 369 LEXINGTON AVENUE 26TH FLOOR NEW YORK NY NEW YORK 10017 (212) 972-0077 DELAWARE None None Limited Partnership true 2018 N/A NGN BioMed I GP, L.P. 369 Lexington Avenue 26th Floor New York NY NEW YORK 10017 Promoter General Partner of the Issuer. N/A NGN Capital LLC 369 Lexington Avenue 26th Floor New York NY NEW YORK 10017 Promoter General Partner of the General Partner of the Issuer. Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.1 false true false true false 0 Indefinite 0 Indefinite false 0 0 true 0 true 0 true The General Partner of the Issuer, or an affiliate of the General Partner of the Issuer, may be entitled to receive a management fee in accordance with the Issuer's governing documentation, as amended from time to time. false NGN Optiscan Fund I, L.P. /s/ Kenneth Abramowitz Kenneth Abramowitz Managing Director of the GP of the GP of the Issuer 2018-04-17